Literature DB >> 28502119

Neutrophil-to-lymphocyte ratio decreases after treatment of psoriasis with therapeutic antibodies.

L Zhang1, C Wiles2, L R Martinez2, G Han1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28502119      PMCID： PMC5685943          DOI： 10.1111/jdv.14334

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  6 in total

1.  Assessments of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in Korean patients with psoriasis vulgaris and psoriatic arthritis.

Authors:  Dae Suk Kim; Dongyun Shin; Min Seok Lee; Hee Ju Kim; Do Young Kim; Soo Min Kim; Min-Geol Lee
Journal:  J Dermatol       Date:  2015-08-18       Impact factor: 4.005

2.  Biologic therapy improves psoriasis by decreasing the activity of monocytes and neutrophils.

Authors:  Keiichi Yamanaka; Yoshinori Umezawa; Akisa Yamagiwa; Hidehisa Saeki; Makoto Kondo; Esteban C Gabazza; Hidemi Nakagawa; Hitoshi Mizutani
Journal:  J Dermatol       Date:  2014-08       Impact factor: 4.005

3.  Therapeutic depletion of myeloid lineage leukocytes in patients with generalized pustular psoriasis indicates a major role for neutrophils in the immunopathogenesis of psoriasis.

Authors:  Shigaku Ikeda; Hidetoshi Takahashi; Yasushi Suga; Hikaru Eto; Takafumi Etoh; Keiko Okuma; Kazuo Takahashi; Takeshi Kanbara; Mariko Seishima; Akimichi Morita; Yasutomo Imai; Takuro Kanekura
Journal:  J Am Acad Dermatol       Date:  2013-01-17       Impact factor: 11.527

4.  A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis.

Authors:  Christopher S Carlin; Steven R Feldman; James G Krueger; Alan Menter; Gerald G Krueger
Journal:  J Am Acad Dermatol       Date:  2004-06       Impact factor: 11.527

5.  Interplay between CXCR2 and BLT1 facilitates neutrophil infiltration and resultant keratinocyte activation in a murine model of imiquimod-induced psoriasis.

Authors:  Hayakazu Sumida; Keisuke Yanagida; Yoshihiro Kita; Jun Abe; Kouji Matsushima; Motonao Nakamura; Satoshi Ishii; Shinichi Sato; Takao Shimizu
Journal:  J Immunol       Date:  2014-03-24       Impact factor: 5.422

6.  The importance of neutrophil lymphocyte ratio in patients with psoriasis.

Authors:  Arzu Ataseven; Aynur Ugur Bilgin; Gulcan Saylam Kurtipek
Journal:  Mater Sociomed       Date:  2014-08-26
  6 in total
  6 in total

1.  Detailed Long-term Dynamics of Neutrophil-to-Lymphocyte Ratio under Biologic Treatment Reveals Differential Effects of Tumour Necrosis Factor-alpha and Interleukin 12/23 Antagonists.

Authors:  Jochen H O Hoffmann; Christian Knoop; Alexander Enk; Eva N Hadaschik
Journal:  Acta Derm Venereol       Date:  2021-09-30       Impact factor: 3.875

2.  Biological depletion of neutrophils attenuates pro-inflammatory markers and the development of the psoriatic phenotype in a murine model of psoriasis.

Authors:  George Han; Annika Havnaer; Hiu Ham Lee; Dylan J Carmichael; Luis R Martinez
Journal:  Clin Immunol       Date:  2019-10-31       Impact factor: 3.969

3.  Evaluation of Psoriasis Area and Severity Index as a Proxy for Bio-markers of Systemic Disease under Treatment with Tumour Necrosis Factor-alpha and Interleukin 12/23 Antagonists in Patients with Psoriasis: A Retrospective Cohort Study of 186 Treatment Cycles.

Authors:  Jochen H O Hoffmann; Christian Knoop; Knut Schäkel; Alexander H Enk; Eva N Hadaschik
Journal:  Acta Derm Venereol       Date:  2021-05-25       Impact factor: 3.875

Review 4.  Role of Neutrophils in Psoriasis.

Authors:  Wen-Ming Wang; Hong-Zhong Jin
Journal:  J Immunol Res       Date:  2020-06-05       Impact factor: 4.818

5.  The Effects of Systemic Psoriasis Therapies on the C-Reactive Protein and the Neutrophil-Lymphocyte Ratio.

Authors:  Ezgi Aktaş Karabay; Aslı Aksu Çerman; Damla Demir; Ilknur Kıvanç Altunay
Journal:  Ann Dermatol       Date:  2019-10-31       Impact factor: 1.444

6.  Effect of Secukinumab on Traditional Cardiovascular Risk Factors and Inflammatory Biomarkers: Post Hoc Analyses of Pooled Data Across Three Indications.

Authors:  Joseph F Merola; Iain B McInnes; Atul A Deodhar; Amit K Dey; Nicholas H Adamstein; Erhard Quebe-Fehling; Maher Aassi; Michael Peine; Nehal N Mehta
Journal:  Rheumatol Ther       Date:  2022-03-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.